Back to Rankings

Steve Jurvetson

Future Ventures

Venture Capital LinkedIn Twitter/X

Platform:

LinkedIn (4) X (42)

#294

LinkedIn Rank

138

Benchmarker Score

Posts

126

Likes

Comments

Avg Likes

Avg Comments

132

Total Engagement

Engagement Rate

2.3

Posts/Week

Weekly

Posting Regularity

Metrics are based on tracked posts and calculated averages. Actual performance may vary.

105,067 followers

Data last refreshed: April 15, 2026

Engagement metrics shown below reflect data as of this date. Current LinkedIn stats may differ.

4 posts

Generative AI works best when solutions are hard to find, but easy to verify. For AI-driven drug development, the challenge has been our complex systems biology making tox and off-target effects h...

Portfolio Company Wins Article Generative AI Drug Discovery Biotech Jan 31, 2026 View on LinkedIn

Likes

Cmnts

Reposts

data as of 15 Feb 2026, 23:25 GMT

Now and then... The Foresight Institute's Vision Weekend is still going strong — a veritable "brain spa" of futurism. Well, it's back to the Future this December: https://lnkd.in/gT-CGPNc + a ti...

Events & Speaking Engagements Image Deep Tech Oct 01, 2025 View on LinkedIn

Likes

Cmnts

Reposts

data as of 24 Jan 2026, 20:08 GMT

The Stanford interview on AI futures just went live, free here: https://lnkd.in/g-qtBQJx "Steve Jurvetson, An Estonian immigrant’s son reflects on a life shaped by technology: inspired by his fath...

Thought Leadership & Future Outlook Image Artificial Intelligence Semiconductors Edge AI AI Agents Robotics Sep 26, 2025 View on LinkedIn

Likes

Cmnts

Reposts

data as of 24 Jan 2026, 20:08 GMT

Printing a vast array of externalized human lymph nodes is a great platform for high-throughput experimentation for AI learning loops. Big pharma agrees.

Thought Leadership & Future Outlook Article Artificial Intelligence Drug Discovery Biotech Synthetic Biology Sep 24, 2025 View on LinkedIn

Likes

Cmnts

Reposts

data as of 24 Jan 2026, 20:08 GMT

Now and then... The Foresight Institute's Vision Weekend is still going strong — a veritable "brain spa" of futurism. Well, it's back to the Future this December: https://lnkd.in/gT-CGPNc + a ti...

Events & Speaking Engagements Oct 01, 2025 View on LinkedIn

Likes

Cmnts

Reposts

data as of 24 Jan 2026, 20:08 GMT

Thought Leadership & Future Outlook Sep 26, 2025 View on LinkedIn

Likes

Cmnts

Reposts

data as of 24 Jan 2026, 20:08 GMT

Generative AI works best when solutions are hard to find, but easy to verify. For AI-driven drug development, the challenge has been our complex systems biology making tox and off-target effects h...

Portfolio Company Wins Jan 31, 2026 View on LinkedIn

Likes

Cmnts

Reposts

data as of 15 Feb 2026, 23:25 GMT

Printing a vast array of externalized human lymph nodes is a great platform for high-throughput experimentation for AI learning loops. Big pharma agrees.

Thought Leadership & Future Outlook Sep 24, 2025 View on LinkedIn

Likes

Cmnts

Reposts

data as of 24 Jan 2026, 20:08 GMT

Now and then... The Foresight Institute's Vision Weekend is still going strong — a veritable "brain spa" of futurism. Well, it's back to the Future this December: https://lnkd.in/gT-CGPNc + a ti...

Events & Speaking Engagements Oct 01, 2025 View on LinkedIn

Likes

Cmnts

Reposts

data as of 24 Jan 2026, 20:08 GMT

Thought Leadership & Future Outlook Sep 26, 2025 View on LinkedIn

Likes

Cmnts

Reposts

data as of 24 Jan 2026, 20:08 GMT

Printing a vast array of externalized human lymph nodes is a great platform for high-throughput experimentation for AI learning loops. Big pharma agrees.

Thought Leadership & Future Outlook Sep 24, 2025 View on LinkedIn

Likes

Cmnts

Reposts

data as of 24 Jan 2026, 20:08 GMT

Generative AI works best when solutions are hard to find, but easy to verify. For AI-driven drug development, the challenge has been our complex systems biology making tox and off-target effects h...

Portfolio Company Wins Jan 31, 2026 View on LinkedIn

Likes

Cmnts

Reposts

data as of 15 Feb 2026, 23:25 GMT

Rank History

No rank history yet

Content Categories

Thought Leadership & Future Outlook 2

Portfolio Company Wins 1

Events & Speaking Engagements 1

Topics & Themes

Artificial Intelligence Drug Discovery Biotech Deep Tech Semiconductors Edge AI AI Agents Robotics Synthetic Biology Generative AI

Top Quartile Benchmarks

Based on top 94 of 375 in Venture Capital

Posts

Steve: 46 ↑

Likes

20,660

Steve: 25,997 ↑

Comments

1,510

Steve: 1,523 ↑

Avg Likes

303.6

Steve: 565.2 ↑

Avg Comments

21.7

Steve: 33.1 ↑

Benchmarker Score

23,680

Steve: 29,043 ↑

Posts/Week

2.9

Steve: 2.3 ↓

Avg Post Length

405 chars

Steve: 1,305 ↑